Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carmustine, Streptozocin, and Mercaptopurine for Refractory Brain Neoplasms
NCT00004688Phase 2Completed
- Sponsor
- Emory University
- Start
- Aug 1996
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of carmustine, streptozocin, mercaptopurine in brain neoplasms, sponsored by Emory University. Started Aug 1996; status: completed.
02
Drugs
carmustinestreptozocinmercaptopurine
03
Conditions
brain neoplasms
Beyond the preview
Go deeper on NCT00004688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004688.